Results 21 to 30 of about 18,434 (234)

Luteal Support and Risk of Ovarian Hyperstimulation in Assisted Reproduction (A Review)

Кубанский научный медицинский вестник, 2020
Background. Gonadotropin-releasing hormone agonist as an ovulation trigger effectively reduces the ovarian hyperstimulation risk in in vitro fertilisation protocols, at the same time requiring an effective luteal phase support in embryo transfer cycles ...
V. A. Krutova, A. A. Baklakova
doaj   +1 more source

Cancer Therapy–Related Cardiac Dysfunction in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The risk of cardiac dysfunction for patients with prostate cancer undergoing androgen deprivation therapy (ADT) in the real‐world setting remains unclear.
Dong‐Yi Chen, Cheng‐Hung Lee, Ming‐Lung Tsai, Ming‐Jer Hsieh, Cheng‐Keng Chuang, See‐Tong Pang, Shao‐Wei Chen, Chi‐Nan Tseng, Shang‐Hung Chang, Pao‐Hsien Chu, I‐Chang Hsieh, Victor Chien‐Chia Wu, Wen‐Kuan Huang   +12 more
doaj   +1 more source

Gonadotrophine Releasing Hormone Agonist As A Trigger of Ovulation in poly cystic ovary syndrome [PDF]

Minia Journal of Medical Research, 2021
Gonadotropin-releasing hormone agonist (GnRH-a) has been used to suppress gonadotropins in several conditions including endometriosis, uterine fibroids, central gonadotropin- dependent precocious puberty, where gonadotropin suppression does not occur ...
Ayman Yousef, Hashem Mohamed, Mamdouh Hamdy, Mohamed Mohamed, Emad Abd El-Moaty   +4 more
doaj   +1 more source

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty

JCRPE, 2021
Objective:A consensus on how to monitor girls with central precocious puberty (CPP) during gonadotropin-releasing hormone agonist (GnRHa) treatment is lacking.
Stefanie Schubert, Amalie H. Hvelplund, Aase Handberg, Søren Hagstroem, Tina Lund Leunbach   +4 more
doaj   +1 more source

Pregnancy Outcomes of Different Endometrial Preparation in Patients With a History of Cesarean Section

Frontiers in Endocrinology, 2022
ObjectiveTo investigate the efficacies of three cycle regimens in women receiving frozen embryo transfer with a history of cesarean section: natural cycle treatment, hormone replacement therapy and treatment with gonadotropin-releasing hormone agonist ...
Run Xin Gan, Run Xin Gan, Yuan Li, Yuan Li, Juan Song, Quan Wen, Quan Wen, Guang Xiu Lu, Guang Xiu Lu, Ge Lin, Ge Lin, Fei Gong, Fei Gong   +12 more
doaj   +1 more source

Kisspeptin Restores Pulsatile LH Secretion in Patients with Neurokinin B Signaling Deficiencies:Physiological, Pathophysiological and Therapeutic Implications [PDF]

, 2012
Pulsatile gonadotropin-releasing hormone (GnRH) is crucial to normal reproductive function and abnormalities in pulse frequency give rise to reproductive dysfunction.
Young, Jacques, Millar, Robert, Brailly-Tabard, Sylvie, Guiochon-Mantel, Anne, Bouligand, Jerome, Millar, Robert P, George, Jyothis, Tello, Javier, Anderson, Richard, Francou, Bruno, Anderson, Richard A, George, Jyothis T, Tello, Javier A   +12 more
core   +1 more source

Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer [PDF]

Endocrine Reviews, 2005
In 1979, the first prostate cancer patient was treated with a GnRH agonist at the Laval University Medical Center in Quebec City, Canada, thus rapidly leading to the worldwide replacement of surgical castration and high doses of estrogens. The discovery of medical castration with GnRH agonists was soon followed by fundamental changes in the endocrine ...
Fernand, Labrie, Alain, Bélanger, Van, Luu-The, Claude, Labrie, Jacques, Simard, Leonello, Cusan, José, Gomez, Bernard, Candas   +7 more
openaire   +2 more sources

A study of association between genetic markers in candidate genes and reproductive traits in one generation of a commercial broiler breeder hen population [PDF]

, 2004
Markers of alleles for three physiological candidate genes for reproductive traits, growth hormone (GHR), gonadotropin-releasing hormone receptor (GNRHR) and neuropeptide Y (NPY) were assessed for the association with the total egg production, number of ...
I C Dunn, A Morris, M N Romanov, Dunn, I C, Morris, A, Y W Miao, Romanov, Michael N, Wilson, P W, Waddington, David, D Waddington, Miao, Yi-Wei, P W Wilson   +11 more
core   +1 more source

pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer

Endocrine Connections, 2019
Estradiol is a key factor for tumorigenesis and prognosis of hormone receptor-positive breast cancer. Adipocytes are one source of estradiol in patients with breast cancer. Recent studies have shown that phosphorylated ribosomal protein S6 kinase-1 plays
Chan Sub Park, Jihye Choi, Min-Ki Seong, Sung-Eun Hong, Jae-Sung Kim, In-Chul Park, Hyesil Seol, Woo Chul Noh, Hyun-Ah Kim   +8 more
doaj   +1 more source

Congenital hypogonadotropic hypogonadism due to GnRH receptor mutations in three brothers reveal sites affecting conformation and coupling [PDF]

, 2012
Congenital hypogonadotropic hypogonadism (CHH) is characterized by low gonadotropins and failure to progress normally through puberty. Mutations in the gene encoding the GnRH receptor (GNRHR1) result in CHH when present as compound heterozygous or ...
Newton, Claire, Young, Jacques, Claire L Newton, Millar, Robert, Newton, Claire L., Guiochon-Mantel Anne, Young Jacques, Guiochon-Mantel, Anne, Millar, Robert P., Bouligand, Jerome, Newton Claire L., Millar, Robert P, Tello Javier A., Tello, Javier, Anne Guiochon-Mantel, Newton, Claire L, Tello, Javier A., Millar Robert P., Robert P Millar, Jerome Bouligand, Jacques Young, Bouligand Jerome, Tello, Javier A, Javier A Tello   +23 more
core   +1 more source